IE40578B1 - New x-ray contrast agents - Google Patents
New x-ray contrast agentsInfo
- Publication number
- IE40578B1 IE40578B1 IE218/75A IE21875A IE40578B1 IE 40578 B1 IE40578 B1 IE 40578B1 IE 218/75 A IE218/75 A IE 218/75A IE 21875 A IE21875 A IE 21875A IE 40578 B1 IE40578 B1 IE 40578B1
- Authority
- IE
- Ireland
- Prior art keywords
- ray contrast
- trioxaundecane
- new
- contrast agents
- medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742405652 DE2405652C3 (de) | 1974-02-04 | 3,6,9-Trioxaundecan-1,11 -dioyl-bis-(3-carboxy-2,4,6-trijod-anilid), dessen Salze mit physiologisch verträglichen Basen, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Röntgenkontrastmittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40578L IE40578L (en) | 1975-08-04 |
| IE40578B1 true IE40578B1 (en) | 1979-07-04 |
Family
ID=5906762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE218/75A IE40578B1 (en) | 1974-02-04 | 1975-02-04 | New x-ray contrast agents |
Country Status (23)
-
1974
- 1974-12-20 DK DK675974A patent/DK675974A/da unknown
-
1975
- 1975-01-23 YU YU0160/75A patent/YU36609B/xx unknown
- 1975-01-28 FI FI750214A patent/FI58589C/fi not_active IP Right Cessation
- 1975-01-28 CS CS75554A patent/CS188213B2/cs unknown
- 1975-01-28 SU SU2101429A patent/SU555848A3/ru active
- 1975-01-31 CH CH113575A patent/CH609565A5/xx not_active IP Right Cessation
- 1975-01-31 IT IT19829/75A patent/IT1060376B/it active
- 1975-01-31 IL IL46535A patent/IL46535A/xx unknown
- 1975-01-31 DD DD183944A patent/DD116141A5/xx unknown
- 1975-02-02 EG EG42A patent/EG11543A/xx active
- 1975-02-03 SE SE7501158A patent/SE409992B/xx not_active IP Right Cessation
- 1975-02-03 GB GB4481/75A patent/GB1501507A/en not_active Expired
- 1975-02-03 AT AT76975A patent/AT338413B/de not_active IP Right Cessation
- 1975-02-03 NO NO750326A patent/NO144595C/no unknown
- 1975-02-04 IE IE218/75A patent/IE40578B1/xx unknown
- 1975-02-04 HU HUSC508A patent/HU168569B/hu unknown
- 1975-02-04 JP JP50014767A patent/JPS5939420B2/ja not_active Expired
- 1975-02-04 ES ES434447A patent/ES434447A1/es not_active Expired
- 1975-02-04 FR FR7503374A patent/FR2259591B1/fr not_active Expired
- 1975-02-04 ZA ZA00750722A patent/ZA75722B/xx unknown
- 1975-02-04 NL NL7501289A patent/NL7501289A/xx not_active Application Discontinuation
- 1975-02-04 CA CA75219351A patent/CA1048536A/en not_active Expired
- 1975-02-04 BE BE153038A patent/BE825160A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU564127B2 (en) | Preparation of barium sulfate for radiographic contrast agent | |
| IL47297A (en) | Derivatives of benzoic acid,their preparation and x-ray contrast media containing them | |
| IE39281B1 (en) | Compisitions for radiographic scanning | |
| ES456690A1 (es) | Un procedimiento para la preparacion de nuevos derivados 1- sustituidos de 4-(diarilmetil) piperazina y de 4 (diarilme- toxi) piperidina. | |
| JPS57165385A (en) | Bispidine derivative, manufacture and medicine containing same | |
| IL62894A (en) | Dibenzoxazepine derivatives,process for preparing the same and pharmaceutical compositions comprising the same | |
| IE42950L (en) | X-ray contrast preparations | |
| ES439927A1 (es) | Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas. | |
| IE44339L (en) | Piperazine derivatives. | |
| IE40578L (en) | New x-ray contrast agents | |
| ES8300332A1 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas | |
| ES427653A1 (es) | Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos. | |
| GR3000831T3 (en) | Piperazine compounds, process for preparing them, pharmaceutical composition and use | |
| GR860679B (en) | Novel 3-pyridylmethylnaphthyl derivatives method for their preparation and their use as medicine | |
| ES376688A1 (es) | Procedimiento para la produccion de una 3h-1,4-benzodiacepi-ra. | |
| ES8302735A1 (es) | "procedimiento para la preparacion de nuevos compuestos de salificacion de acidos colicos con trimebutina". | |
| GB1387803A (en) | Watersoluble salts of polyhydroxyphenylchromanones | |
| ES470226A1 (es) | Procedimiento para la preparacion de 4-fenil-8-amino-tetra- hidroisoquinoleinas | |
| GB1388863A (en) | Hydroxy- and alkoxy-acetamido-triiodobenzoic acids | |
| GB1470748A (en) | 6-2-pyridyl-4h-s-triazolo-4,3-a-1,4-benzodiazepines | |
| Kormano et al. | Intravenous prostaglandin and the gallbladder | |
| GB1467528A (en) | Piperazinium 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolyl acetate | |
| ES455692A1 (es) | Procedimiento para la produccion de derivados de alquilen- dioxipiperacina. | |
| HU9401978D0 (en) | Process for producing pharmaceutical compositions containing beta-naphtoquinone derivatives or salts thereof for inhibiting blood platelet aggregation | |
| DE3674250D1 (de) | Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung. |